175 related articles for article (PubMed ID: 30709654)
21. Corrigendum to "Detection of visual and frontoparietal network perfusion deficits in Parkinson's disease dementia" [Eur. J. Radiol. 144 (2021) 109985].
Azamat S; Arslan DB; Erdogdu E; Kicik A; Cengiz S; Eryürek K; Tufekcioğlu Z; Bilgic B; Hanagasi H; Demiralp T; Gurvit H; Ozturk-Isik E
Eur J Radiol; 2022 Dec; 157():110570. PubMed ID: 36327858
[No Abstract] [Full Text] [Related]
22. Corrigendum to "MRI radiomics for the preoperative evaluation of lymphovascular invasion in breast cancer: A meta-analysis" [Eur. J. Radiol. 168 (2023) 111127].
Ma Q; Li Z; Li W; Chen Q; Liu X; Feng W; Lei J
Eur J Radiol; 2024 Jan; 170():111226. PubMed ID: 38056346
[No Abstract] [Full Text] [Related]
23. Corrigendum to "Is there a role for perfusion imaging in assessing treatment response following ablative therapy of small renal masses-A systematic review" [Eur. J. Radiol. Open 5 (2018) 102-107].
Withey SJ; Gariani J; Reddy K; Prezzi D; Kelly-Morland C; Ilyas S; Adam A; Goh V
Eur J Radiol Open; 2019; 6():e1. PubMed ID: 31886320
[TBL] [Abstract][Full Text] [Related]
24. Corrigendum to "The combination of endoluminal radiofrequency ablation and metal stent implantation for the treatment of malignant biliary stenosis - Randomized study". [Eur. J. Radiol. 142 (2021) 109830].
Andrasina T; Rohan T; Panek J; Kovalcikova P; Kunovsky L; Ostrizkova L; Valek V
Eur J Radiol; 2022 Mar; 148():110180. PubMed ID: 35114534
[No Abstract] [Full Text] [Related]
25. Corrigendum to "RECIST 1.1, Choi and mChoi criteria in the evaluation of tumor response in patients with metastatic colorectal cancer treated with Regorafenib and anti-PD-1 antibody" [Eur. J. Radiol. 141 (2021) 109823].
Li L; Xu Y; Yang Y; Ye F; Zhang H; Zhou A; Zhao X
Eur J Radiol; 2021 Sep; 142():109897. PubMed ID: 34371308
[No Abstract] [Full Text] [Related]
26. Corrigendum to "COV is a readily available quantitative indicator of metabolic heterogeneity for predicting survival of patients with early and locally advanced NSCLC manifesting as central lung cancer" [Eur. J. Radiol. 132 (2020) 109338].
Zhao P; Pan Z; Yu T
Eur J Radiol; 2020 Dec; 133():109401. PubMed ID: 33199189
[No Abstract] [Full Text] [Related]
27. Corrigendum to "INternational Soft Tissue saRcoma ConsorTium (INSTRuCT) consensus statement: Imaging recommendations for the management of rhabdomyosarcoma" [Eur. J. Radiol. 166 (2023) 111012].
Schoot RA; van Ewijk R; von Witzleben AA; Kao SC; Hans Merks JHM; Morosi C; Pace E; Shulkin BL; Ferrari A; von Kalle T; van Rijn RR; Weiss AR; Sparber-Sauer M; Ter Horst SAJ; Beth McCarville M
Eur J Radiol; 2023 Nov; 168():111108. PubMed ID: 37774530
[No Abstract] [Full Text] [Related]
28. Corrigendum to "Overview of trials on artificial intelligence algorithms in breast cancer screening - A roadmap for international evaluation and implementation" [Eur. J. Radiol. 167 (2023) 111087].
van Nijnatten TJA; Payne NR; Hickman SE; Ashrafian H; Gilbert FJ
Eur J Radiol; 2024 Jan; 170():111202. PubMed ID: 37988959
[No Abstract] [Full Text] [Related]
29. Corrigendum to "Atherosclerotic carotid artery disease Radiomics: A systematic review with meta-analysis and radiomic quality score assessment" [Eur. J. Radiol. 177 (2024) 111547].
Vacca S; Scicolone R; Gupta A; Allan Wasserman B; Song J; Nardi V; Yang Q; Benson J; Lanzino G; Paraskevas KI; Suri JS; Saba L
Eur J Radiol; 2024 Jun; 177():111583. PubMed ID: 38944908
[No Abstract] [Full Text] [Related]
30. Corrigendum to "Evaluation of breast cancer malignancy, prognostic factors and molecular subtypes using a continuous-time random-walk MR diffusion model" [Eur. J. Radiol. 166 (2023) 111003].
Chang H; Wang D; Li Y; Xiang S; Yang YX; Kong P; Fang C; Ming L; Wang X; Zhang C; Jia W; Yan Q; Liu X; Zeng Q
Eur J Radiol; 2023 Dec; 169():111158. PubMed ID: 37897958
[No Abstract] [Full Text] [Related]
31. Corrigendum to "Rim enhancement on hepatobiliary phase of pre-treatment 3.0 T MRI: A potential marker for early chemotherapy response in colorectal liver metastases treated with XELOX" [Eur. J. Radiol. 143 (2021) 109887].
Wang X; Wang Y; Zhang Z; Zhou M; Zhou X; Zhao H; Xing J; Zhou Y
Eur J Radiol; 2022 Mar; 148():110154. PubMed ID: 35016131
[No Abstract] [Full Text] [Related]
32. The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines from 2001 to 2017.
Song P; Cai Y; Tang H; Li C; Huang J
Biosci Trends; 2017; 11(4):389-398. PubMed ID: 28904327
[TBL] [Abstract][Full Text] [Related]
33. Advancement in HCC imaging: diagnosis, staging and treatment efficacy assessments: imaging diagnosis and staging of hepatocellular carcinoma.
Choi BI; Lee JM
J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):369-73. PubMed ID: 19967573
[TBL] [Abstract][Full Text] [Related]
34. Corrigendum to "Anticoagulation status post radiofrequency ablation in a patient with hepatocellular carcinoma and delayed bleeding event" [Radiol Case Rep 15 (2020) 1381-1385].
Adaramola O; Solomon N; Anyanwu F; Desrosiers A; Smith M
Radiol Case Rep; 2020 Oct; 15(10):2051. PubMed ID: 32952748
[TBL] [Abstract][Full Text] [Related]
35. Erratum to 'Prostate cancer local staging using biparametric MRI: Assessment and comparison with multiparametric MRI' [Eur. J. Radiol. 132 (2020) 109350].
Christophe C; Montagne S; Bourrelier S; Roupret M; Barret E; Rozet F; Comperat E; Coté JF; Lucidarme O; Cussenot O; Granger B; Renard-Penna R
Eur J Radiol; 2020 Dec; 133():109417. PubMed ID: 33229110
[No Abstract] [Full Text] [Related]
36. Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines.
Ayuso C; Rimola J; Vilana R; Burrel M; Darnell A; García-Criado Á; Bianchi L; Belmonte E; Caparroz C; Barrufet M; Bruix J; Brú C
Eur J Radiol; 2018 Apr; 101():72-81. PubMed ID: 29571804
[TBL] [Abstract][Full Text] [Related]
37. A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016.
Yu SJ
Clin Mol Hepatol; 2016 Mar; 22(1):7-17. PubMed ID: 27044761
[TBL] [Abstract][Full Text] [Related]
38. A model to estimate survival in ambulatory patients with hepatocellular carcinoma: Can it predict the natural course of hepatocellular carcinoma?
Choi WM; Yu SJ; Ahn H; Cho H; Cho YY; Lee M; Yoo JJ; Cho Y; Lee DH; Cho EJ; Lee JH; Kim YJ; Yoon JH
Dig Liver Dis; 2017 Nov; 49(11):1273-1279. PubMed ID: 28807489
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology and treatment of hepatocellular carcinoma in Thailand.
Chonprasertsuk S; Vilaichone RK
Jpn J Clin Oncol; 2017 Apr; 47(4):294-297. PubMed ID: 28042136
[TBL] [Abstract][Full Text] [Related]
40. Corrigendum to 'Extracellular signal-regulated kinase, receptor interacting protein, and reactive oxygen species regulate shikonin-induced autophagy in human hepatocellular carcinoma' [Eur. J. Pharmacol. 738 (2014) 142-152].
Gong K; Zhang Z; Chen Y; Shu HB; Li W
Eur J Pharmacol; 2020 Oct; 884():173462. PubMed ID: 32838984
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
